View Cart (0 items)

Pharmaceutical

Pfizer to sell infant nutrition unit

No Comments
NEW YORK — Pfizer Inc. has decided to sell its infant nutrition business as soon as next week, The New York Times reported. According to the story, Nestle appears
Read More

Idaho settles GlaxoSmithKline case for $2.6 million

No Comments
BOISE, Idaho — Drugmaker GlaxoSmithKline has agreed to pay the state of Idaho $2.6 million to settle allegations that the company sold products at false or inflated prices, CNBC
Read More

J&J fined $1.1 billion in antipsychotic drug case

No Comments
LITTLE ROCK, Ark. — An Arkansas judge ordered Johnson & Johnson to pay more than $1.1 billion in fines after a jury found the company’s officials misled doctors and
Read More

Pfizer cuts employee severance package to reduce costs

No Comments
NEW YORK — Pfizer Inc. is cutting its employee severance package after May 14 in an effort to reduce costs, Bloomberg reported. The pharmaceutical giant, which has fired 26,000
Read More

U.S. pharmaceutical outsourcing shows post-recession gains

No Comments
The upturn in the fortunes of pharmaceutical companies after the recession is mirrored by the U.S. contract manufacturing outsourcing (CMO) market, which is expected to grow at a compound
Read More

Blocked piping may have caused explosion at pharmaceutical plant

No Comments
EDINBURGH, UK — Blocked piping may have caused a chemical alert at a pharmaceutical company in Edinburgh, BBC News reported. Emergency crews were called to reports of a small
Read More

GlaxoSmithKline to build new facilities in UK

No Comments
TEL AVIV, Israel — GlaxoSmithKline PLC announced Thursday that it would invest more than $794 million to build its first U.K. plant in 40 years and to add to
Read More

Pfizer to pay $3.3 million to settle antibiotic marketing case

No Comments
SALEM, Ore. — Pfizer Inc. has agreed to pay the state of Oregon more than $3.3 million to settle claims that the company used misleading statements and studies to
Read More

Feds demand $1.8 billion from J&J to resolve Risperdal civil claims

No Comments
WASHINGTON — The U.S. government has demanded that Johnson & Johnson raise its offer by $800 million from an initial proposal to settle a federal civil investigation into marketing
Read More

Pfizer sues Johnson & Johnson for patent infringement

No Comments
NEW YORK — Pfizer Inc. is seeking unspecified damages in a patent infringement lawsuit against a unit of Johnson & Johnson over pain-relieving heat-patch technology, Bloomberg reported. Fort Washington,
Read More